EcoDrugPlus

Ensembl ID : ENSOTSG00005027821
Gene Symbol: -
Cross references: -
58 Possible Orthologues:

Ensembl ID : ENSOTSG00005020336
Gene Symbol: -
Cross references: -
49 Possible Orthologues:

Ensembl ID : ENSOTSG00005019502
Gene Symbol: -
Cross references: -
153 Possible Orthologues:

Ensembl ID : ENSOTSG00005022316
Gene Symbol: -
Cross references: -
177 Possible Orthologues:

Ensembl ID : ENSOTSG00005019731
Gene Symbol: -
Cross references: -
185 Possible Orthologues:

Ensembl ID : ENSOTSG00005023350
Gene Symbol: -
Cross references: -
175 Possible Orthologues:

Ensembl ID : ENSOTSG00005026356
Gene Symbol: -
Cross references: -
140 Possible Orthologues:

Ensembl ID : ENSOTSG00005028476
Gene Symbol: RPS3A
1 Cross references
357 Possible Orthologues:

Ensembl ID : ENSOTSG00005028909
Gene Symbol: -
Cross references: -
262 Possible Orthologues:

Ensembl ID : ENSOTSG00005019845
Gene Symbol: -
Cross references: -
214 Possible Orthologues:

Ensembl ID : ENSOTSG00005020406
Gene Symbol: -
Cross references: -
206 Possible Orthologues:

Ensembl ID : ENSOTSG00005033095
Gene Symbol: -
Cross references: -
240 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).